On April 7, ​​Perkins Coie’s CXO Summit gathered more than 50 C-suite and board leaders for an executive leadership virtual forum addressing how technology is shaping healthcare’s future amid the COVID-19 pandemic.

The CXO Summit participants discussed how technology is being used to further combat COVID-19, monitor patient diagnostics, augment clinical workflows, detect fraud and data breaches, and inform effective treatments, among other key tasks and medical interventions.

In his keynote remarks, Dean of the Brown University School of Public Health Ashish Jha, outlined how technology, data, and artificial intelligence can help inform and improve healthcare policy decisions. He noted the dichotomy between promoting public health and the economy was false: “We can optimize for both.” He added that COVID-19 will prompt society to chart new relationships with work, data, and public health.

C-suite representatives and board members from a range of Fortune 1000 companies discussed how businesses, researchers, and policymakers could find a path forward to combat complex healthcare challenges using technology and data while also addressing privacy and security risks all amid public policy challenges to COVID-19.

For example, participants discussed how interoperability challenges at the beginning of the pandemic led to duplication of efforts and lessons learned for collaboration between governments and businesses moving forward, especially when speed and scale are critical in improving healthcare outcomes. Participants also heard about paradigm shifts in consumer data, including models in which data is anonymized and added to platforms to improve the public health journey for all.

It’s clear that healthcare technology will play a role in addressing current and future public health challenges. The CXO Summit demonstrated that investors, financial institutions, retailers, and apps can all contribute to a coordinated health response.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of David T. Biderman David T. Biderman

David Biderman, a partner in Perkins Coie’s San Francisco and Los Angeles offices, focuses his practice on mass tort litigation and consumer class actions. He heads the firm’s Mass Tort and Consumer Litigation group. He has represented a wide variety of companies in…

David Biderman, a partner in Perkins Coie’s San Francisco and Los Angeles offices, focuses his practice on mass tort litigation and consumer class actions. He heads the firm’s Mass Tort and Consumer Litigation group. He has represented a wide variety of companies in state and federal courts in California for 30 years.

On consumer class actions, David represents packaged food companies, coffee companies, dairy companies, footwear companies and others whose nutritional or health claims have been challenged. He also has represented search engines and other online companies. He has a record of favorable results for clients. He successfully tried a major consumer fraud class action on behalf of one of the world’s major search engines in a case involving online gambling advertisements. For that same client, he negotiated a favorable settlement of a class action challenging its online advertising pricing. He represented a major coffee retailer in defeating a class action on standing grounds. He also has litigated pre-emption defenses arising out of food labeling and obtained a dismissal for a client whose nutritional statements were challenged.

For fifteen years, David managed the firm’s full-service product liability team responsible for defending over 1,000 toxic tort cases pending in Los Angeles and Northern California state courts. These cases entailed ongoing trial activity at various levels for several trials set each month. The highly experienced and well-coordinated team has handled thousands of asbestos toxic tort cases for a variety of clients, including FORTUNE 500 companies from such industries as consumer products, aerospace manufacturing, household goods, dry cleaning and industries that generate electromagnetic fields, such as electric utilities and operators of wireless communications systems.

Photo of Tommy Tobin Tommy Tobin

Thomas Tobin’s practice focuses on complex commercial litigation and class action matters involving statutory, constitutional, and regulatory issues in a range of industries, including food and beverage, consumer packaged goods, and cannabis. In the food and beverage sector, Tommy has experience defending false…

Thomas Tobin’s practice focuses on complex commercial litigation and class action matters involving statutory, constitutional, and regulatory issues in a range of industries, including food and beverage, consumer packaged goods, and cannabis. In the food and beverage sector, Tommy has experience defending false advertising claims and consumer protection claims for well-known international corporations.